Precision BioSciences (DTIL) came out with quarterly earnings of $3.46 per share, beating the Zacks Consensus Estimate of a loss of $0.77 per share. This compares to loss of $3 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 549.35%. A quarter ago, it was expected that this genome editing company would post a loss of $0.45 per share when it actually produced a loss of $0.35, delivering a surprise of 22.22%. Over the last four ...